Carlos H. Caldas
The University of Texas at Austin
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Single-cell and spatial transcriptomics
Strong evidence · 5 supporting papers · latest 2026
Cancer Immunotherapy and Biomarkers
Strong evidence · 4 supporting papers · latest 2026
Construction Project Management and Performance
Solid evidence · 1 supporting paper · latest 2026
Cancer Cells and Metastasis
Solid evidence · 2 supporting papers · latest 2026
Breast Cancer Treatment Studies
Solid evidence · 2 supporting papers · latest 2026
PI3K/AKT/mTOR signaling in cancer
Solid evidence · 1 supporting paper · latest 2026
Immune cells in cancer
Solid evidence · 2 supporting papers · latest 2026
Cancer Genomics and Diagnostics
Solid evidence · 1 supporting paper · latest 2026
Publications (12)
Enhanced prediction of breast cancer patient response to chemotherapy by integrating deconvolved expression patterns of immune, stromal and tumor cells
2025DOIPMID 41176212
Differences and challenges in collaborative risk management across different project delivery methods
2026DOI
Real-time cell viability monitoring for high-throughput drug screening using tumor xenograft-derived cells
2026DOIPMID 42202786
The tumor microenvironment of 14,837 breast cancers is associated with clinical outcome independently of genomic subtypes
2025DOIPMID 41218603
Predicting neoadjuvant breast cancer therapy response using BRIDGE from tumor transcriptomics and histopathology
2026DOIPMID 42203036
Abstract B047: Path2Space: An AI approach for cancer biomarker discovery via histopathology inferred spatial transcriptomics
2025DOI
Chemotherapy reshapes cellular clonal landscape via persister programs in breast cancer xenografts
2026DOI
Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancer.
2026DOI
Supplementary Data1 from PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2− Breast Cancer: Clinical and Circulating Tumor DNA Results
2026DOI
1086 Enhanced prediction of chemotherapy response in breast cancer via integrating deconvolved expression patterns of immune, stromal and tumor cells in tumor microenvironment
2025DOI
Supplemental Materials
2026DOI
Supplemental Materials
2026DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- The University of Texas at Austin
Source: OpenAlex · retrieved 2026-09-29